1. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma;Gambhir;J Nucl Med,1996
2. FDG-PET in solitary pulmonary nodules: a German cost-effectiveness analysis [abstract];Weber;J Nucl Med,1997
3. A theoretical decision analysis model for the cost effectiveness of newly emerging coincidence imaging (CI) technology in the presurgicaal staging of non-small cell lung carcinoma (NSCLC) [abstract];Gambhir;J Nucl Med,1997
4. Effectiveness of whole-body FDG PET in staging of non-small-cell lung cancer (NSCLC) [abstract];Steinert;J Nucl Med,1998
5. Cost effectiveness analysis of FDG-PET in the differential diagnosis and staging of lung cancer in Japan;Kubota;Kaku Igaku (Jpn J Nucl Med),1997